In the present study, we enriched the metabolic pathway, glutathione, by metabolomics analysis, and due to the dysregulation of the glutathione metabolic pathway, the expression of Nrf2 was reduced in ovarian cancer cells in the combination group compared with the control group and the single-agent group (Figures 4L,M). This evidence concerns the gene NFE2L2 and ovarian cancer.